These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Retinal dysfunction in cancer-associated retinopathy is improved by Ca(2+) antagonist administration and dark adaptation. Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2589-95. PubMed ID: 11581204 [Abstract] [Full Text] [Related]
3. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Ohguro H, Ogawa K, Maeda T, Maeda A, Maruyama I. Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3160-7. PubMed ID: 10586938 [Abstract] [Full Text] [Related]
4. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Maeda A, Ohguro H, Maeda T, Wada I, Sato N, Kuroki Y, Nakagawa T. Cancer Res; 2000 Apr 01; 60(7):1914-20. PubMed ID: 10766180 [Abstract] [Full Text] [Related]
6. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Ohguro H, Ogawa K, Nakagawa T. Invest Ophthalmol Vis Sci; 1999 Jan 01; 40(1):82-9. PubMed ID: 9888430 [Abstract] [Full Text] [Related]
8. Growth of the postnatal rat retina in vitro: quantitative RT-PCR analyses of mRNA expression for photoreceptor proteins. Liljekvist-Larsson I, Törngren M, Abrahamson M, Johansson K. Mol Vis; 2003 Dec 09; 9():657-64. PubMed ID: 14685147 [Abstract] [Full Text] [Related]
16. Pathological roles of recoverin in cancer-associated retinopathy. Ohguro H, Nakazawa M. Adv Exp Med Biol; 2002 Sep 30; 514():109-24. PubMed ID: 12596918 [Abstract] [Full Text] [Related]
17. Recoverin, a photoreceptor-specific calcium-binding protein, is expressed by the tumor of a patient with cancer-associated retinopathy. Polans AS, Witkowska D, Haley TL, Amundson D, Baizer L, Adamus G. Proc Natl Acad Sci U S A; 1995 Sep 26; 92(20):9176-80. PubMed ID: 7568096 [Abstract] [Full Text] [Related]